0001144204-13-021894.txt : 20130415 0001144204-13-021894.hdr.sgml : 20130415 20130415170211 ACCESSION NUMBER: 0001144204-13-021894 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20130415 DATE AS OF CHANGE: 20130415 GROUP MEMBERS: MELECHDAVID, INC. FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Groussman Mark CENTRAL INDEX KEY: 0001552880 FILING VALUES: FORM TYPE: SC 13G MAIL ADDRESS: STREET 1: 100 S POINTE DRIVE #1405 CITY: MIAMI BEACH STATE: FL ZIP: 33139 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MusclePharm Corp CENTRAL INDEX KEY: 0001415684 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770664193 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-85226 FILM NUMBER: 13761870 BUSINESS ADDRESS: STREET 1: 4721 IRONTON STREET CITY: DENVER STATE: CO ZIP: 80239 BUSINESS PHONE: (800) 210-7369 MAIL ADDRESS: STREET 1: 4721 IRONTON STREET CITY: DENVER STATE: CO ZIP: 80239 FORMER COMPANY: FORMER CONFORMED NAME: Tone in Twenty DATE OF NAME CHANGE: 20071018 SC 13G 1 v341464_sc13g.htm SCHEDULE 13G

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

SCHEDULE 13G

(Rule 13d-102)

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO RULE 13d-1(b) (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO

RULE 13d-2(b)

 

MusclePharm Corporation
(Name of Issuer)
 
COMMON STOCK, $0.001 par value
(Title of Class of Securities)
 
627335102
(CUSIP Number)

 

Copy to:
Harvey Kesner, Esq.
Sichenzia Ross Friedman Ference LLP
61 Broadway, 32nd Floor
New York, NY 10006

 

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

 

March 28, 2013
(Date of Event Which Requires Filing of This Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

¨ Rule 13d-1(b)

x Rule 13d-1(c)

¨ Rule 13d-1(d)

 

 
 

 

 

CUSIP No. 627335102

 

 

 

1

 

 

NAME OF REPORTING PERSONS

S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

Mark Groussman

 

2

 

 

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

 

(a) ¨

(b) ¨

 

 

3

 

 

SEC USE ONLY

 

 

 

4

 

 

CITIZENSHIP OR PLACE OF ORGANIZATION

 

United States

 

 

 

NUMBER OF SHARES

 

5

 

 

SOLE VOTING POWER

 

0

 

BENEFICIALLY

OWNED BY

 

6

 

 

SHARED VOTING POWER

 

570,000 (1)

 

EACH

REPORTING

 

7

 

 

SOLE DISPOSITIVE POWER

 

 

0

 

PERSON WITH

 

8

 

 

SHARED DISPOSITIVE POWER

 

570,000 (1)

 

9

 

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

570,000 (1)

 

 

10

 

 

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

 

 

 

11

 

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

8.36% (based on 6,816,159 shares of common stock issued and outstanding as of March 31, 2013)

 

 

12

 

 

TYPE OF REPORTING PERSON*

 

IN

 

(1)Includes 570,000 shares of common stock held by Melechdavid, Inc. (“Melechdavid”). Mark Groussman is the President of Melechdavid and in such capacity holds voting and dispositive power over shares held by Melechdavid.

 

 
 

 

 

CUSIP No. 627335102

 

 

 

 

1

 

 

NAME OF REPORTING PERSONS

S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

Melechdavid, Inc.

 

2

 

 

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a) ¨

(b) ¨

 

 

3

 

 

SEC USE ONLY

 

 

 

4

 

 

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Florida

 

 

 

NUMBER OF SHARES

 

 

5

 

 

SOLE VOTING POWER

 

0

 

BENEFICIALLY

OWNED BY

 

 

6

 

 

SHARED VOTING POWER

 

570,000

 

EACH

REPORTING

 

 

7

 

 

SOLE DISPOSITIVE POWER

 

0

 

PERSON WITH

 

 

8

 

 

SHARED DISPOSITIVE POWER

 

570,000

 

9

 

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

570,000

 

 

10

 

 

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

 

 

 

11

 

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

8.36% (based on 6,816,159 shares of common stock issued and outstanding as of March 31, 2013)

 

 

12

 

 

TYPE OF REPORTING PERSON*

 

CO

 

 

 
 

 

Item 1(a). Name of Issuer:

 

MusclePharm Corporation

 

Item 1(b). Address of Issuer's Principal Executive Offices:

 

4721 Ironton Street, Building A

Denver, CO 90839

 

Item 2(a). Name of Person Filing.

 

The statement is filed on behalf of Mark Groussman and Melechdavid, Inc. (“Melechdavid”).

 

Item 2(b). Address of Principal Business Office or, if None, Residence.

 

4400 Biscayne Boulevard, Miami, Florida 33137

 

Item 2(c). Citizenship.

 

United States/Florida

 

Item 2(d). Title of Class of Securities.

 

Common Stock, par value $0.001 per share.

 

Item 2(e). CUSIP Number.

 

627335102

 

Item 3. Type of Person

 

Not applicable.

 

Item 4.     Ownership.

 

(a) Amount beneficially owned: 570,000 (1).

 

(b) Percent of class: 8.36%.

 

(c) Number of shares as to which the person has:

 

(i) Sole power to vote or to direct the vote: 0.

 

(ii) Shared power to vote or to direct the vote: 570,000 (1).

 

(iii) Sole power to dispose or to direct the disposition of: 0.

 

(iv) Shared power to dispose or to direct the disposition of: 570,000 (1).

 

(1) Includes 570,000 shares of common stock held by Melechdavid.  Mark Groussman is the President of Melechdavid and in such capacity holds voting and dispositive power over shares held by Melechdavid.

 

Item 5.     Ownership of Five Percent or Less of a Class.

 

Not applicable.

 

Item 6.    Ownership of More than Five Percent on Behalf of Another Person.

 

Not applicable

 

 
 

 

Item 7.    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported by the Parent Holding Company.

 

Not applicable.

 

Item 8.     Identification and Classification of Members of the Group.

 

Not applicable.

 

Item 9.     Notice of Dissolution of Group.

 

Not applicable.

 

Item 10.     Certifications.

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

 
 

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

    Melechdavid, Inc.
Date: April 15, 2013 By:  /s/ Mark Groussman
    Mark Groussman
    President
     
Date: April 15, 2013 By:  /s/ Mark Groussman
    Mark Groussman